The proteins of the surfactant system

The structural and functional integrity of pulmonary surfactant depends on several specific proteins. Two of these, SP-A and SP-D, are large and water-soluble, while SP-B and SP-C are small and very hydrophobic. SP-A is an 18-mer of 26 kDa polypeptide chains and contains N-linked oligosaccharides. Structurally, it can be characterized as a collagen/lectin hybrid. Together with SP-B, SP-A is required for conversion of secreted endogenous surfactant to tubular myelin in the alveolar lining. It also regulates surfactant secretion and reuptake of surfactant lipids by type II cells; these functions are probably receptor mediated. SP-D, a 12-mer of 39 kDa polypeptide chains, is a collagenous glycoprotein with structural similarities to C-type lectins. Both SP-A and SP-D stimulate alveolar macrophages. SP-B is a 79-residue polypeptide that contains three intrachain disulphide bridges. It exists mainly as a homodimer, which is strongly positively charged and may selectively remove anionic and unsaturated lipid species from the alveolar surface film, thereby increasing surface pressure. SP-C is a mainly alpha-helical, extraordinarily hydrophobic polypeptide containing 35 amino acid residues and covalently linked palmitoyl groups. Its alpha-helical portion is inserted into surfactant lipid bilayers. SP-C accelerates the adsorption of lipid bilayers to an interfacial monolayer. In babies with respiratory distress syndrome, the clinical response to treatment with surfactant containing SP-B and SP-C is much faster than in babies treated with protein-free synthetic surfactant. We speculate that, in the near future, surfactant preparations based on recombinant hydrophobic proteins will be available for clinical use.

This article has been cited by other articles:

				E. Gastiasoro-Cuesta, F. J. Alvarez-Diaz, C. Rey-Santano, A. Arnaiz-Renedo, B. Loureiro-Gonzalez, and A. Valls-i-Soler Acute and Sustained Effects of Lucinactant Versus Poractant-{alpha} on Pulmonary Gas Exchange and Mechanics in Premature Lambs With Respiratory Distress Syndrome Pediatrics, February 1, 2006; 117(2): 295 - 303. [Abstract] [Full Text] [PDF]

				K. Tashiro, K. Ohta, X. Cui, K. Nishizuka, K. Yamamoto, T. Konzaki, T. Kobayashi, and Y. Suzuki Effects of various forms of surfactant protein C on tidal volume in ventilated immature newborn rabbits J Appl Physiol, April 1, 2003; 94(4): 1519 - 1526. [Abstract] [Full Text] [PDF]

				K.E. Greene, T.E. King Jr, Y. Kuroki, B. Bucher-Bartelson, G.W. Hunninghake, L.S. Newman, H. Nagae, and R.J. Mason Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis Eur. Respir. J., March 1, 2002; 19(3): 439 - 446. [Abstract] [Full Text] [PDF]

				K. Tashiro, K. Yamada, T. Konzaki, K. Yamamoto, S. Ohmura, T. Kobayashi, and Y. Suzuki Aerosolized surfactant therapy for endotoxin-induced experimental acute respiratory distress syndrome in rats Br. J. Anaesth., August 1, 2001; 87(2): 266 - 271. [Abstract] [Full Text] [PDF]

				C. von Bredow, P. Birrer, and M. Griese Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis Eur. Respir. J., April 1, 2001; 17(4): 716 - 722. [Abstract] [Full Text] [PDF]

				N. J. Miller, S. Orgeig, C. B. Daniels, and R. V. Baudinette Postnatal development and control of the pulmonary surfactant system in the tammar wallaby Macropus eugenii J. Exp. Biol., January 12, 2001; 204(23): 4031 - 4042. [Abstract] [Full Text] [PDF]

				P. Rauprich, O. Moller, G. Walter, E. Herting, and B. Robertson Influence of Modified Natural or Synthetic Surfactant Preparations on Growth of Bacteria Causing Infections in the Neonatal Period Clin. Vaccine Immunol., September 1, 2000; 7(5): 817 - 822. [Abstract] [Full Text] [PDF]

				S. W. Glasser, M. S. Burhans, S. K. Eszterhas, M. D. Bruno, and T. R. Korfhagen Human SP-C gene sequences that confer lung epithelium-specific expression in transgenic mice Am J Physiol Lung Cell Mol Physiol, May 1, 2000; 278(5): L933 - L945. [Abstract] [Full Text] [PDF]

				C. HERMANS and A. BERNARD Lung Epithelium-specific Proteins . Characteristics and Potential Applications as Markers Am. J. Respir. Crit. Care Med., February 1, 1999; 159(2): 646 - 678. [Full Text]

				P. J. Borron, E. C. Crouch, J. F. Lewis, J. R. Wright, F. Possmayer, and L. J. Fraher Recombinant Rat Surfactant-Associated Protein D Inhibits Human T Lymphocyte Proliferation and IL-2 Production J. Immunol., November 1, 1998; 161(9): 4599 - 4603. [Abstract] [Full Text] [PDF]

				R. J. Mason, K. Greene, and D. R. Voelker Surfactant protein A and surfactant protein D in health and disease Am J Physiol Lung Cell Mol Physiol, July 1, 1998; 275(1): L1 - L13. [Abstract] [Full Text] [PDF]

				S.-H. Yu and F. Possmayer Interaction of pulmonary surfactant protein A with dipalmitoylphosphatidylcholine and cholesterol at the air/water interface J. Lipid Res., March 1, 1998; 39(3): 555 - 568. [Abstract] [Full Text]

				T. Kobayashi, K. Tashiro, K. Yamamoto, S. Nitta, S. Ohmura, and Y. Suzuki Effects of surfactant proteins SP-B and SP-C on dynamic and static mechanics of immature lungs J Appl Physiol, December 1, 1997; 83(6): 1849 - 1856. [Abstract] [Full Text] [PDF]

				G. Grossmann, Y. Suzuki, B. Robertson, T. Kobayashi, P. Berggren, W.-Z. Li, G.-W. Song, and B. Sun Pathophysiology of neonatal lung injury induced by monoclonal antibody to surfactant protein B J Appl Physiol, June 1, 1997; 82(6): 2003 - 2010. [Abstract] [Full Text] [PDF]

				S. A. Buchanan, M. C. Mauney, V. I. Parekh, N. F. DeLima, O. A. R. Binns, J. T. Cope, K. S. Shockey, C. G. Tribble, and I. L. Kron Intratracheal Surfactant Administration Preserves Airway Compliance During Lung Reperfusion Ann. Thorac. Surg., December 1, 1996; 62(6): 1617 - 1621. [Abstract] [Full Text]

				Z. Wang, O. Gurel, J. E. Baatz, and R. H. Notter Acylation of Pulmonary Surfactant Protein-C Is Required for Its Optimal Surface Active Interactions with Phospholipids J. Biol. Chem., August 9, 1996; 271(32): 19104 - 19109. [Abstract] [Full Text] [PDF]